CD44 has also been implicated in the homing of CLL cells into the spleen, as genetic deletion or neutralization of CD44 with blocking antibodies impairs CLL accumulation in the spleen in vivo [138,139]. The gene discussed is CD44; the disease is B-cell chronic lymphocytic leukemia.